Skip to content

Evaluation of the effectiveness of climbazole shampoo treatment.

A survey in effectiveness of ketoconazole versus climbazole shampoo in the treatment of tinea versicolor .

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190811044510N1
Enrollment
60
Registered
2019-11-07
Start date
2019-09-23
Completion date
Unknown
Last updated
2019-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

tinea versicolor. Pityriasis versicolor

Interventions

Intervention 1: Intervention group: patients are treated with shampoo climbazole 2%(Asaderm company)for 3 weeks ,3 days a week and do not wash the foam for 10 minutes. Intervention 2: Control group: I

Sponsors

Kerman University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to No maximum

Inclusion criteria

Inclusion criteria: Patient with tinea versicolor Limited skin disease that does not require systemic treatment

Exclusion criteria

Exclusion criteria: Underlying systemic disease Pregnancy and lactation Taking any topical or systemic antifungal drug since the onset of the disease history of allergy to climbazole

Design outcomes

Primary

MeasureTime frame
Fluorescence of lesion. Timepoint: At the beginning of the study ( before intervention) ,4 weeks and 12 weeks after intervention. Method of measurement: wood lamp.;Effectiveness based on mycological smear KOH. Timepoint: At the beginning of the study ( before intervention) ,4 weeks and 12 weeks after intervention. Method of measurement: Lab evaluation of KOH smear.

Secondary

MeasureTime frame
Patients symptoms( example :itching ,color variation and scaling). Timepoint: At the beginning of the study (before intervention), 4 weeks and 12 weeks after intervention. Method of measurement: Clinical examination through observation.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZiba Omidvand

Kerman University of Medical Sciences

z.omidvand@kmu.ac.ir+98 34 3132 8237

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026